Infectious Diseases News and Research

RSS

Surface Structure Impacts Quorum Signaling of Bacteria Across Biofilms

Similar to how cells within human tissues communicate and function together as a whole, bacteria are also able to communicate with each other through chemical signals, a behavior known as quorum signaling (QS).

5 Apr 2023

Dengue Viruses Subvert Mosquito Biology to Tamp Down Human Immune Responses

The saliva of mosquitoes infected with dengue viruses contains a substance that thwarts the human immune system and makes it easier for people to become infected with these potentially deadly viruses, new research reveals.

5 Apr 2023

Designing a Lipid Nanoparticle to Safely Deliver mRNA to the Pancreas

Therapeutics that use mRNA-;like some of the COVID-19 vaccines-;have enormous potential for the prevention and treatment of many diseases.

4 Apr 2023

UConn Health scientists explain why Shigella bacteria can infect humans but not mice

Shigella bacteria can infect humans but not mice. In the March 29 issue of Nature, a team from UConn Health explains why. Their findings may explain the multifariousness of a key weapon of our immune system.

31 Mar 2023

COVID-19 vaccines boost the levels of T cells in immunocompromised hematology patients

Researchers found that, despite being heavily immunocompromised, hematology patients generate strong cellular immune responses against SARS-CoV-2 after vaccination, on par with that of healthy individuals.

30 Mar 2023

Myeloid cells contribute to a long-lived HIV reservoir, study shows

A subset of white blood cells, known as myeloid cells, can harbor HIV in people who have been virally suppressed for years on antiretroviral therapy, according to findings from a small study supported by the National Institutes of Health.

28 Mar 2023

New compound may offer a way to prevent serious C. diff infections

Each year, about 500,000 people in the U.S. deal with gastrointestinal infections from Clostridioides difficile (C. diff), and more than 20,000 die from these infections.

27 Mar 2023

Common Epstein-Barr virus may be a trigger for multiple sclerosis

In 1868, French physician Jean-Martin Charcot, known as the founder of modern neurology, defined a disease entity in which multiple plaques formed in the brain and spinal cord, with varying physical symptoms, called Sclérose en plaques, or in English as multiple sclerosis (MS).

24 Mar 2023

Study describes why COVID-19 subvariants accelerated the pandemic

The COVID-19 pandemic has killed nearly 7 million people worldwide (1.1 million in the United States) and severely harmed many millions more, though vaccines and antiviral treatments measurably reduced the potential loss of life and health.

23 Mar 2023

Novel tool analyzes how immune cells respond to SARS-CoV-2 vaccination

A study discovered that the magnitude and quality of a key immune cell’s response to two doses of the Pfizer-BioNTech COVID-19 vaccine were significantly lower in individuals with earlier SARS-CoV-2 infection compared to individuals without previous infection.

21 Mar 2023

New antibody "cocktail" may help counter the Lassa virus

The finding, made with the use of the Advanced Photon Source, shows a new way to exploit monoclonal antibodies to subvert the "shield" of the virus, potentially paving the way for new therapies.

20 Mar 2023

New therapeutic approaches to treat autoimmune diseases using a metabolite

Researchers have revealed the modulatory effect of the anti-inflammatory metabolite itaconate on T helper and T regulatory cells, which may lead to new therapeutic approaches to treating some autoimmune diseases.

16 Mar 2023

Applying crocodile’s unique pH sensing mechanism to benefit humans

Researchers from La Trobe University have just discovered how crocodiles, despite living in dirty water, prevent deadly fungal infections by employing a unique pH sensing mechanism.

3 Mar 2023

SXSW 2023 to focus on the critical role microbes in human health

Rebecca Bart, PhD, member at the Donald Danforth Plant Science Center, and her colleagues from Washington University in St. Louis will be featured on a global stage at South by Southwest on March 11 at 2:30 PM at the JW Marriott, Austin Texas.

28 Feb 2023

Insilico Medicine: IND application for first generative AI-designed drug for COVID-19 approved

Insilico Medicine, a clinical-stage biotech company powered by generative AI, today announces that China National Medical Products Administration (NMPA) has approved the Investigational New Drug (IND) application for ISM3312, an orally available 3CLpro inhibitor generated and designed with the support of Insilico's proprietary generative chemistry platform Chemistry42 for the treatment of COVID-19.

24 Feb 2023

Earthquakes pose severe long-term impacts on the health of Syrian refugees

Among those in greatest peril after the devasting earthquakes in the Middle East are some 6.6 million internally displaced persons in Syria, as well as 1.9 million Syrian refugees living in Turkey, according to estimations from the United Nations High Commissioner for Refugees.

24 Feb 2023

Genetic study emphasizes the significance of “balancing selection” in evolution

Nature can maintain various genetic features in balance as a species grows over millions of years, much like a merchant of old would do when balancing the weights of two distinct products on a scale.

23 Feb 2023

Limiting antibiotic use in livestock associated with reduction in antibiotic-resistant infection

A California policy restricting antibiotic use in animals raised for food is associated with a reduction in one type of antibiotic-resistant infection in people in the state, according to a new study published today in the journal Environmental Health Perspectives.

23 Feb 2023

Mount Sinai researchers reveal mechanisms underlying autoimmunity in Down syndrome

Scientists at the Icahn School of Medicine at Mount Sinai in New York have identified which parts of the immune system go awry and contribute to autoimmune diseases in individuals with Down syndrome.

23 Feb 2023

Study shows how convalescent plasma can be used as effective treatment during future pandemics

Three years into the COVID-19 pandemic, new variant outbreaks continue to fuel economic disruptions and hospitalizations across the globe.

22 Feb 2023

Infectious Diseases News and Research

Surface Structure Impacts Quorum Signaling of Bacteria Across Biofilms

Dengue Viruses Subvert Mosquito Biology to Tamp Down Human Immune Responses

Designing a Lipid Nanoparticle to Safely Deliver mRNA to the Pancreas

UConn Health scientists explain why Shigella bacteria can infect humans but not mice

COVID-19 vaccines boost the levels of T cells in immunocompromised hematology patients

Myeloid cells contribute to a long-lived HIV reservoir, study shows

New compound may offer a way to prevent serious C. diff infections

Common Epstein-Barr virus may be a trigger for multiple sclerosis

Study describes why COVID-19 subvariants accelerated the pandemic

Novel tool analyzes how immune cells respond to SARS-CoV-2 vaccination

New antibody "cocktail" may help counter the Lassa virus

New therapeutic approaches to treat autoimmune diseases using a metabolite

Applying crocodile’s unique pH sensing mechanism to benefit humans

SXSW 2023 to focus on the critical role microbes in human health

Insilico Medicine: IND application for first generative AI-designed drug for COVID-19 approved

Earthquakes pose severe long-term impacts on the health of Syrian refugees

Genetic study emphasizes the significance of “balancing selection” in evolution

Limiting antibiotic use in livestock associated with reduction in antibiotic-resistant infection

Mount Sinai researchers reveal mechanisms underlying autoimmunity in Down syndrome

Study shows how convalescent plasma can be used as effective treatment during future pandemics

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics